Sinofert Holdings Limited logo

Sinofert Holdings Limited

0297.HK

HKSEBasic MaterialsAgricultural Inputs

Latest quote

HK$1.28

HK$0.00 · 0.00%

Aug 24, 11:48 AM HKT

0297.HK company overview

Regular session · HKT · Market data may be delayed.

Company profile

Company website

Sinofert Holdings Limited, an investment holding company, engages in the production, import and export, distribution, and retail of fertilizer raw materials and crop nutrition products in Mainland China and internationally. The company operates through Basic Business, Growth Business, and Production segments. It offers potash, phosphate, bio-compound, special, and nitrogen fertilizers; sulfur, crop protection, and seeds; and monocalcium and dicalcium phosphate. The company also provides technological research and development, and services relating to crop nutrition business and products; trades in fertilizers; develops agriculture products; and manufactures and sells feeds. In addition, it explores for and exploits a phosphate mine. The company was founded in 1993 and is based in Wan Chai, Hong Kong. Sinofert Holdings Limited operates as a subsidiary of Syngenta Group (Hk) Holdings Company Limited.

Industry
Agricultural Inputs
Sector
Basic Materials
Headquarters
HK
CEO
Tie Lin Wang
Listed since
Jun 7, 2004
Employees
4,407

Market position

Day range

Current HK$1.28

52-week range

Current HK$1.28

Open
HK$1.285
Previous close
HK$1.28
Volume
12.85M
0.43× average
Average volume
29.77M
Average daily volume
Market cap
8.99B HKD
Beta
0.7
Market reference 1
50-day average
HK$1.2987
-1.44% below average
200-day average
HK$1.5232
-15.97% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
8.08B CNY
P/E (TTM)
6.03×
P/B (TTM)
0.69×
P/S (TTM)
0.33×
EV / EBITDA
4.5×
Earnings yield
13.22%
Free cash flow yield
17.55%
Dividend yield
7.34%

Profitability & efficiency

Gross margin
12.35%
Operating margin
6.44%
Net margin
5.41%
Return on equity
11.22%
Return on assets
5.34%
Return on invested capital
9.37%

Financial health

Debt / equity
0.13×
Current ratio
1.24×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends13%10%6%2%Gross margin, FY2021: 8.42%Gross margin, FY2022: 9.95%Gross margin, FY2023: 10.40%Gross margin, FY2024: 11.76%Gross margin, FY2025: 12.35%Operating margin, FY2021: 3.06%Operating margin, FY2022: 4.58%Operating margin, FY2023: 4.54%Operating margin, FY2024: 4.98%Operating margin, FY2025: 6.44%Net margin, FY2021: 3.83%Net margin, FY2022: 4.86%Net margin, FY2023: 2.88%Net margin, FY2024: 4.99%Net margin, FY2025: 5.41%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 8.42%. Gross margin FY2022 9.95%. Gross margin FY2023 10.40%. Gross margin FY2024 11.76%. Gross margin FY2025 12.35%. Operating margin FY2021 3.06%. Operating margin FY2022 4.58%. Operating margin FY2023 4.54%. Operating margin FY2024 4.98%. Operating margin FY2025 6.44%. Net margin FY2021 3.83%. Net margin FY2022 4.86%. Net margin FY2023 2.88%. Net margin FY2024 4.99%. Net margin FY2025 5.41%.

Income trends

Revenue

23.26B CNY+9.40%

Operating income

1.5B CNY+41.60%

Net income

1.26B CNY+18.64%
Income trends across reported periods25.53B CNY16.47B CNY7.42B CNY−1.64B CNYRevenue, FY2021: 22.64B CNYRevenue, FY2022: 23B CNYRevenue, FY2023: 21.73B CNYRevenue, FY2024: 21.26B CNYRevenue, FY2025: 23.26B CNYOperating income, FY2021: 692.72M CNYOperating income, FY2022: 1.05B CNYOperating income, FY2023: 985.72M CNYOperating income, FY2024: 1.06B CNYOperating income, FY2025: 1.5B CNYNet income, FY2021: 866.61M CNYNet income, FY2022: 1.12B CNYNet income, FY2023: 625.55M CNYNet income, FY2024: 1.06B CNYNet income, FY2025: 1.26B CNYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 22.64B CNY. Revenue FY2022 23B CNY. Revenue FY2023 21.73B CNY. Revenue FY2024 21.26B CNY. Revenue FY2025 23.26B CNY. Operating income FY2021 692.72M CNY. Operating income FY2022 1.05B CNY. Operating income FY2023 985.72M CNY. Operating income FY2024 1.06B CNY. Operating income FY2025 1.5B CNY. Net income FY2021 866.61M CNY. Net income FY2022 1.12B CNY. Net income FY2023 625.55M CNY. Net income FY2024 1.06B CNY. Net income FY2025 1.26B CNY.
Metric (CNY)FY2025FY2024FY2023FY2022FY2021
Revenue23.26B CNY21.26B CNY21.73B CNY23B CNY22.64B CNY
Cost of goods sold20.39B CNY18.76B CNY19.47B CNY20.71B CNY20.73B CNY
Gross profit2.87B CNY2.5B CNY2.26B CNY2.29B CNY1.91B CNY
Selling, general, and administrative1.4B CNY1.37B CNY1.22B CNY1.27B CNY1.29B CNY
Operating expenses1.38B CNY1.44B CNY1.27B CNY1.14B CNY1.21B CNY
Interest income134.64M CNY110.27M CNY110.74M CNY62.26M CNY48.37M CNY
Interest expense45.08M CNY57.38M CNY69.64M CNY22.51M CNY17M CNY
Depreciation and amortization418.92M CNY350.89M CNY432.72M CNY223.64M CNY187.81M CNY
Operating income1.5B CNY1.06B CNY985.72M CNY1.05B CNY692.72M CNY
Net income1.26B CNY1.06B CNY625.55M CNY1.12B CNY866.61M CNY

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
0.02

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates0.210.140.070Q3 '22Q3 '23Q4 '23Q3 '24Q4 '24Q1 '25Q3 '25Q1 '26
Q3 2022, reported Aug 23, 2022: actual 0.148, estimate —, surprise —, Comparison unavailable. Q3 2023, reported Aug 28, 2023: actual 0.146, estimate —, surprise —, Comparison unavailable. Q4 2023, reported Oct 30, 2023: actual 0.151, estimate —, surprise —, Comparison unavailable. Q3 2024, reported Aug 26, 2024: actual 0.161, estimate —, surprise —, Comparison unavailable. Q4 2024, reported Oct 30, 2024: actual 0.161, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 25, 2025: actual 0.002, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 25, 2025: actual 0.172, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Mar 26, 2026: actual 0.025, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates29.91B22.22B14.54B6.86BQ3 '22No estimateQ3 '23MissQ4 '23MissQ3 '24MissQ4 '24MissQ1 '25No estimateQ3 '25No estimateQ1 '26No estimate
Q3 2022, reported Aug 23, 2022: actual 17.93B HKD, estimate —, surprise —, Comparison unavailable. Q3 2023, reported Aug 28, 2023: actual 14.19B HKD, estimate 28.29B HKD, surprise -49.85%, Miss. Q4 2023, reported Oct 30, 2023: actual 14.2B HKD, estimate 25.91B HKD, surprise -45.20%, Miss. Q3 2024, reported Aug 26, 2024: actual 14.7B HKD, estimate 28.03B HKD, surprise -47.56%, Miss. Q4 2024, reported Oct 30, 2024: actual 14.69B HKD, estimate 28.21B HKD, surprise -47.93%, Miss. Q1 2025, reported Mar 25, 2025: actual 8.07B HKD, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 25, 2025: actual 16.12B HKD, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Mar 26, 2026: actual 9.51B HKD, estimate —, surprise —, Comparison unavailable.

0297.HK peers

ETFs holding 0297.HK

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research 0297.HK

research.disclaimer